Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Authors: Victor F. Tapson, Fernando Torres, F. Kermeen, Anne Keogh, Roblee P. Allen, Robert P. Frantz, David B. Badesch, Adaani Frost, Shelley Shapiro, Kevin Laliberte, J Sigman, Carl Arneson, Nazzareno Galiè - CHEST Journal 2012 cited by 376